LQDA
LIQUIDIA CORP
Health Care·Pharmaceuticals·UNITED STATES
$68.66
MCap $6.1B
as of 2026-09-04
Total
B9w
Fund
C9w
Quant
A10w
Price
▲ Up▼ Down━ MA30━ MA100━ Mean┄ U┄ L
MIDOS % pane · green > 90 long zone · red < 10 short zone · reference lines at 10 / 90
MIDOS SI
as of 2026-09-04
MIDOS SI
+0.48
Sentiment 19.1%
−3 oversold0+3 overbought
Signal
NEUTRAL
Actual
$68.66
Adaptive Mean
$66.89
+1.77 vs mean
Adaptive σ
1.84
MIDOS BB
$63.20 – $70.57
center ± 2σ adaptive
Fundamental Factors (Sector-Relative Z)
as of 2026-09-04
Composite Z
+1.01
ROE
131.8%
Z +0.72
Rev Gr
1842.7%
Z +4.91
EPS Gr
—
Z +0.12
OPM Gr
1181.7%
Z +0.36
FCF Yld
1.2%
Z +0.11
EPS Surp
-0.1%
Z +0.14
EPS 3mo Δ
2495.0%
Z +0.71
Fwd P/E
12.15
Z —
PEGY
N/A
growth + yield ≤ 0
Momentum (Risk-Adjusted Alpha)
as of 2026-09-04
Q3M
4.38
Q6M
10.89
Q12M
8.44
MA 30/100
1.165
Bullish (MA30 > MA100)
α (Jensen)
0.4501
β (12M)
0.93
σ (12M)
0.654
Divergence — Fundamentals vs Momentum
Z Percentile
98%
Q Percentile
94%
Divergence
+4.3
Tier
ALIGNED
Fundamentals and momentum roughly in line.
Kirkpatrick RS & Persistence
RS
102.8
RS Pctl
98%
RS Decile
D10
Persistence
9w
at grade B
Options / OI Analysis
as of 2026-08-10
OI Center
$72.54
-20.0% from spot
Max Pain
$80.00
PCR (OI)
1.34
neutral
Skew
-0.66
OI Composite
-1
neutral
Direction
strong_bearish